GLUE
#2002
Monte Rosa Therapeutics, Inc. - Common Stock
23.4 0 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.26%
Monthly Change
+29.71%
6 month change
-4.33%
Year Change
+107.08%
Previous Close
23.4 6
Open
23.4 3
Low
23.3 0
High
23.5 0
Volume
214
Financials
- Market Capitalization 1.98 B
- Employee 161
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.09
Price to sales ratio
32.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1987 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.87 USD | -0.69% | -0.31% | -1.31% | +33.03% | 2.04 B USD | ||
| 1990 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 34.30 USD | -1.47% | -8.61% | -0.23% | +11.00% | 1.99 B USD | ||
| 2004 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.21 USD | +0.68% | -1.54% | +17.93% | -14.43% | 1.98 B USD | ||
| 2013 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -0.22% | +16.97% | +118.43% | 1.98 B USD |
Frequently asked questions about Monte Rosa Therapeutics, Inc. - Common Stock
What is the Monte Rosa Therapeutics, Inc. - Common Stock stock price today?
The current price of Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) is 23.4. Over the past 24 hours, the stock has changed by -0.26%. Follow the GLUE chart for real-time price dynamics.
What is the stock ticker of Monte Rosa Therapeutics, Inc. - Common Stock?
Monte Rosa Therapeutics, Inc. - Common Stock trades under the ticker GLUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Monte Rosa Therapeutics, Inc. - Common Stock stock going up?
GLUE has changed by +0.26% over the last week, +29.71% over the last month, and +107.08% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Monte Rosa Therapeutics, Inc. - Common Stock net income for the last quarter?
Monte Rosa Therapeutics, Inc. - Common Stock reported net income of -44.5 M for the last quarter. The previous quarter showed -46.13 M, which means net income changed by +3.54%.
How many employees does Monte Rosa Therapeutics, Inc. - Common Stock have?
As of the latest available data, Monte Rosa Therapeutics, Inc. - Common Stock has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Monte Rosa Therapeutics, Inc. - Common Stock EBITDA?
Monte Rosa Therapeutics, Inc. - Common Stock EBITDA is -47.36 M, and its EBITDA margin is -1 124.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Monte Rosa Therapeutics, Inc. - Common Stock stock?
You can buy Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Monte Rosa Therapeutics, Inc. - Common Stock stock?
Investing in Monte Rosa Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GLUE chart and related analysis on metatrader.com as part of your research.